Abstract
Medication-overuse headache is a worldwide challenge as it affects 1–2% of the general population. Some people are more prone to medication overuse, which can be ascertained by applying five simple questions about dependence. Detoxification of the overused medication is a cheap and effective treatment strategy. A short advice seems to be sufficient for people from the general population whom seek their general practitioner. Treatment is often more complicated in neurologist and hospital settings, most likely due to a combination of treatment failure in general practice and co-morbidity of other disorders including different types of headaches.
Similar content being viewed by others
References
Peters GA, Horton BT (1951) Headache with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Staff Meet Mayo Clin 26:153–161
Tfelt-Hansen P, Johnson ES (1993) Ergotamine. In: Olesen J, Tfelt-Hansen P, Welch KM (eds) The headaches. Raven Press, New York, pp 313–322
Ad Hoc Committee on Classification of Headache (1962) Classification of headache. JAMA 179:717–718
Headache Classification Subcommittee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl 7):1–196
Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24(Suppl 1):1–160
Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629–808
Headache Classification Committee of the International Headache Society (2018) The International Classification of Headache Disorders. Cephalalgia 38:1–211
Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ (2001) Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 21:980–986
Colás R, Muñoz P, Temprano R et al (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62:1338–1342
Wang SJ, Fuh JL, Lu SR, Juang KD (2006) Chronic daily headache in adolescents. Prevalence, impact, and medication overuse. Neurology 66:193–197
Aaseth K, Grande RB, Kværner KJ et al (2008) Prevalence of secondary chronic headaches in a population-based sample of 30–44-year-old persons. The Akershus study of chronic headache. Cephalalgia 28:705–713
Westergaard ML, Hansen EH, Glümer C, Olesen J, Jensen RH et al (2014) Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia 34:409–425
Kristoffersen ES, Lundqvist C (2014) Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf 5:87–99
Russell MB, Rasmussen BK, Brennum J, Iversen HK, Jensen RA, Olesen J (1992) Presentation of a new instrument: the diagnostic headache diary. Cephalalgia 12:369–374
Seng EK, Robbins MS, Nicholson RA (2017) Acute migraine medication adherence, migraine disability and patient satisfaction: a naturalistic daily diary study. Cephalalgia 37:955–964
Giffin NJ, Lipton RB, Silberstein SD, Olesen J, Goadsby PJ (2016) The migraine postdrome: an electronic diary study. Neurology 87:309–313
Gossop M, Darke S, Griffiths P et al (1995) The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90:607–614
Grande RB, Aaseth K, Saltyte Benth J, Gulbrandsen P, Russell MB, Lundqvist C (2009) The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headache. J Neurol Neurosurg Psychiatry 80:784–789
Lundqvist C, Aaseth K, Grande RB, Benth JŠ, Russell MB (2010) The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache. Pain 148:487–491
Lundqvist C, Benth JŠ, Grande RB et al (2011) An adapted Severity of Dependence Scale is valid for the detection of medication overuse: the Akershus study of chronic headache. Eur J Neurol 18:512–518
Kaye S, Darke S (2002) Determining a diagnostic cut-off on the Severity of Dependence Scale (SDS) for cocaine dependence. Addiction 97:727–731
Lawrinson P, Copeland J, Gerber S, Gilmour S (2007) Determining a cut-off on the Severity of Dependence Scale (SDS) for alcohol dependence. Addict Behav 32:1474–1479
Martin G, Copeland J, Gates P, Gilmour S (2006) The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off. Drug Alcohol Depend 83:90–93
Topp L, Mattick RP (1997) Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 92:839–845
Grande RB, Aaseth K, Benth JŠ, Lundqvist C, Russell MB (2011) Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol 18:129–137
Kristoffersen ES, Straand J, Vetvik KG, Benth JŠ, Russell MB, Lundqvist C (2015) Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial. J Neurol Neurosurg Psychiatry 86:505–512
Kristoffersen ES, Straand J, Vetvik KG, Benth JŠ, Russell MB, Lundqvist C (2016) Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial. J Neurol 263:344–353
Aaseth K, Grande RB, Lundkvist C et al (2009) What is chronic headache in the general population? The Akershus study of chronic headache. Acta Neurol Scand 120(Suppl 189):30–32
Evers S, Jensen R, European Federation of Neurological Societies (2011) Treatment of medication overuse headache - guideline of the EFNS headache panel. Eur J Neurol 18:1115–1121
Tassorelli C, Jensen R, Allena M, de Icco R, Sances G, Katsarava Z, Lainez M, Leston JA, Fadic R, Spadafora S, Pagani M, Nappi G, the COMOESTAS Consortium (2014) A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study. Cephalalgia 34:645–655
Tassorelli C, Jensen R, Allena M, COMOESTAS Consortium et al (2017) The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: a controlled multicentre study. Cephalalgia 37:1115–1125 2016
de las Cuevas C, Sanz EJ, de la Fuente JA et al (2000) The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction 95:245–250
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Ethical considerations
This is a review article–based paper. The reference studies comply with the ethical standards. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Russell, M.B. Epidemiology and management of medication-overuse headache in the general population. Neurol Sci 40 (Suppl 1), 23–26 (2019). https://doi.org/10.1007/s10072-019-03812-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-019-03812-8